Dr. Zervos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2415 N Orange Ave
Ste 700
Orlando, FL 32804Phone+1 407-303-2474
Summary
- Dr. Zervos is the medical director of liver transplant and the Associate Chair of Abdominal Transplantation Center at the Cleveland Clinic Florida. He received his medical degree from Nova Southeastern University College of Osteopathic Medicine and has been in practice 13 years. He also speaks multiple languages, including Greek and Medical Spanish. He specializes in hepatology & liver transplantation and is experienced in general gastroenterology, hepatology, viral hepatitides, hepatitis c, non-alcoholic fatty liver disease, and liver cancers.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Gastroenterology, 2008 - 2011
- University of Miami/Jackson Health SystemFellowship, Transplant Hepatology, 2007 - 2008
- Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 2006 - 2007
- UPMC Medical Education/MercyResidency, Internal Medicine, 2004 - 2006
- Nova Southeastern University College of Osteopathic MedicineClass of 2004
Certifications & Licensure
- FL State License 2007 - 2026
- GA State License 2024 - 2026
- NY State License 2024 - 2026
- CT State License 2024 - 2025
- NC State License 2024 - 2025
- PA State License 2004 - 2024
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
- To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure Start of enrollment: 2014 Apr 01
- Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF) Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 40 citationsFibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.Nikhil Kapila, Kawtar Al-Khalloufi, Pablo A. Bejarano, Jason M. Vanatta, Xaralambos Zervos
American Journal of Transplantation. 2020-02-01 - 88 citationsHepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus–Negative Recipients: A Real-World ExperienceNikhil Kapila, K. V. Narayanan Menon, Kawtar Al-Khalloufi, Jason M. Vanatta, Carla Murgas
Hepatology. 2020-07-01 - 220 citationsCholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.Naga Chalasani, Arthur R. Baluyut, Ayaaz Ismail, Atif Zaman, Gagan Sood
Hepatology. 2000-01-01
Press Mentions
- 2,000 Organ Transplants and Counting at Cleveland Clinic Weston HospitalAugust 27th, 2024
Other Languages
- Greek, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: